“This report forecasts the global pharmacovigilance market to grow from US$ 8.3 billion in 2024 to US$ 19.4 billion by 2035 (CAGR 7.9%), driven by rising drug consumption, expanding clinical trials, and a shift toward outsourced, AI-enabled safety monitoring services.”